India’s first indigenous vaccine against the H5N1 strain of bird flu in chickens was unveiled in Bhopal on Tuesday. Developed by scientists at the Indian Council of Agricultural Research’s National Institute of High Security Animal Diseases (NIHSAD), the vaccine is priced at ₹1-2 per dose and is expected to strengthen disease prevention in the poultry sector and reduce economic losses, a scientist said.

Union agriculture and farmers’ welfare and rural development minister Shivraj Singh Chouhan unveiled the vaccine. Describing animal husbandry and poultry as vital pillars of the rural economy, he said livestock function as “moving ATMs” for farmers, providing a regular source of income alongside agriculture. He said animal husbandry contributes 14% to India’s GDP, while the poultry sector accounts for another 1%, and cited average annual losses from livestock diseases, including ₹22,000 crore from foot-and-mouth disease and ₹20,000 crore from Lumpy Skin Disease.

The research team comprised Dr S Nagarajan, Dr Manoj Kumar, Dr C Tosh, Dr H.V. Murugkar, Dr Aniket Sanyal, Dr Senthil Kumar D., Dr Naveen Kumar and Dr Yogisharadhya R. A NIHSAD scientist said the vaccine is the world’s first against this particular variant of bird flu and is expected to protect the livelihoods of millions of poultry farmers. Chouhan said the scientists worked under stringent biosafety protocols, and announced a new state-of-the-art laboratory in Bhopal at an estimated cost of ₹300 crore.

India’s first bird flu outbreak was reported in Navapur, Maharashtra, in 2006, resulting in the death of nearly one million chickens. Since then, the country has witnessed more than 500 outbreaks, with around nine lakh chickens dying in 2021 and another two lakh this year. Chouhan also took a swipe at Opposition leaders for allegedly questioning India’s constitutional institutions and scientific capabilities while speaking abroad, without naming Congress leader Rahul Gandhi.